Copper Peptides (GHK-Cu)vsResveratrol

GHK-Cu activates wound repair genes through copper-dependent transcription factor modulation. It stimulates fibroblasts to produce collagen types I, III, and V via COL1A1, COL3A1, COL5A1 upregulation, plus elastin, decorin, and glycosaminoglycans. Copper serves as cofactor for lysyl oxidase (collagen cross-linking). It attracts macrophages and mast cells releasing PDGF, TGF-beta, FGF. Promotes angiogenesis via VEGF. Uniquely activates MMP-2 and MMP-9 to break down damaged collagen and scar tissue — supporting healthy remodeling. Balanced anabolic-catabolic activity explains efficacy in anti-aging and scar revision. Avoid with vitamin C: copper catalyzes Fenton reactions oxidizing ascorbic acid.

Resveratrol activates SIRT1 (sirtuin 1), a NAD+-dependent deacetylase that deacetylates histones and non-histone targets including p53, FOXO transcription factors, and NF-κB, regulating cellular stress response, DNA repair, autophagy, and inflammatory pathways in keratinocytes and fibroblasts. It scavenges superoxide anion, hydroxyl radical, and metal-induced free radicals through its phenolic hydroxyl groups. Resveratrol inhibits NF-κB nuclear translocation and downstream cytokine production (TNF-α, IL-1β, IL-6), reducing UV-induced inflammation. It inhibits tyrosinase (mild brightening), matrix metalloproteinase-9 (MMP-9, gelatinase B) to prevent collagen and elastin breakdown, and AP-1 (c-Fos/c-Jun) to reduce photoaging-related gene expression. It may also activate Nrf2, upregulating antioxidant enzymes (HO-1, NQO1). Topical application achieves higher skin tissue concentrations than oral supplementation due to first-pass metabolism. Stability is improved in anhydrous or encapsulated formulations.